Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
allogeneic bone marrow derived mesenchymal stem cell (1 trial)
platelet rich plasma (1 trial)
autologous bone marrow derived mesenchymal cells (1 trial)
Back Pain (Phase 3)
Hematoma (Phase 3)
Intervertebral Disc Degeneration (Phase 3)
Low Back Pain (Phase 3)
Rupture (Phase 3)
Xerostomia (Phase 2)
Trials (3 total)
Trial APIs (3 total)